Outcomes Associated with Initial versus Later Vancomycin Use in Patients with Complicated Skin and Skin-Structure Infections
BackgroundBackground Delayed coverage of pathogens including meticillin-resistant Staphylococcus aureus (MRSA) in pneumonia and bacteraemia has been associated with increased mortality and length of hospital stay (LOS). However, less is known about the impact of delayed appropriate coverage in complicated skin and skin-structure infections (cSSSIs). Abstract: ObjectiveObjective To evaluate the clinical and economic outcomes associated with early versus late use of vancomycin in the management of patients hospitalized for cSSSIs. Abstract: MethodsMethods Retrospective analysis was performed using an inpatient claims database of >500 US hospitals in 2005. Using prescription claims, patients with primary or secondary cSSSI admissions were classified into three groups: 1 - early vancomycin monotherapy; 2 - early vancomycin combination therapy; 3 - late vancomycin therapy. Outcomes studied included LOS and inpatient hospital costs. One-way analysis of variance was used for unadjusted analysis and multivariate regression methods were used to control for co-variates. Abstract: ResultsResults A total of 34 942 patients (27.78% of all patients with cSSSIs) were treated with vancomycin. Mean age was 54.7 years and 54.3% of the patients were males. Mean unadjusted total LOS was 8.46, 9.44 and 13.2 days, and hospital costs in 2005 values were $US10 211.94, $US12 361.94 and $US18 344.00 for groups 1, 2 and 3, respectively. In-hospital mortality rate was highest in group 3 (4.18%) and lowest in group 1 (1.75%). Generalized linear models used to control for potential confounding variables between early versus late vancomycin use suggest that among cSSSI patients late vancomycin use is an independent predictor of higher LOS and costs. Abstract: ConclusionConclusion In this large inpatient database, later vancomycin use in patients with cSSSIs appears to be significantly associated with higher LOS and total costs.
Year of publication: |
2009
|
---|---|
Authors: | Itani, Kamal M.F. ; Akhras, Kasem S. ; Stellhorn, Robert ; Quintana, Alvaro ; Budd, David ; Merchant, Sanjay |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 27.2009, 5, p. 421-430
|
Publisher: |
Springer Healthcare | Adis |
Saved in:
Online Resource
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
Persistent link: https://www.econbiz.de/10004993639
Saved in favorites
Similar items by subject
-
Five-Year Evolution of Drug Prescribing in a University Adult Intensive Care Unit
Carron, Christine, (2012)
-
White, Judith, (2012)
-
Baumler, Michael Bumler, (2012)
- More ...
Similar items by person
-
Comparisons of Hypertension-Related Costs from Multinational Clinical Studies
Mullins, C. Daniel, (2004)
- More ...